Koblenz - CompuGroup Medical, one of the world's leading e-health providers, recorded revenues of EUR 1,154.0 million in the 2024 financial year, 3 percent below the previous year's level (PY: EUR 1,187.7 million), which was attributable to high one-off effects in the previous year. Organically, revenues were 2 percent below the prior year. At EUR  [ … ]

Closing of the transaction is expected in the second quarter of 2025, subject to regulatory approvals Delisting offer planned shortly after successful completion of the transaction – no increase over the current tender offer price expected CVC has secured a minority stake of 21.85% in CompuGroup Medical while founding family Gotthardt retains maj [ … ]

Successful conclusion of initial acceptance period of CVC offer for CompuGroup Medical – Additional acceptance period from 29 January to 11 February 2025  Tender offer successful (subject to regulatory approvals): At the end of the acceptance period, CVC holds 20.43% of total share capital and voting rights in CompuGroup Medical Additional accept [ … ]

CVC exceeds minimum acceptance threshold for voluntary public tender offer for CompuGroup Medical – additional acceptance period expected to commence on 29 January Minimum acceptance threshold of 17% exceeded Tender offer successful (subject to regulatory approvals), paving the way for strategic partnership to take effect As of today, 17.46% of  [ … ]

CGM issues joint reasoned statement recommending that shareholders accept CVC's voluntary public takeover offer   Offer price of EUR 22.00 per share is considered to be fair and adequate Deutsche Bank and J.P. Morgan have issued fairness opinions confirming the fairness of the offer price from a financial perspective Managing Directors, Adminis [ … ]